Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,204,402
  • Shares Outstanding, K 95,470
  • Annual Sales, $ 276,740 K
  • Annual Income, $ 2,640 K
  • 60-Month Beta 0.84
  • Price/Sales 7.94
  • Price/Cash Flow 71.14
  • Price/Book 6.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.04
  • Number of Estimates 4
  • High Estimate 0.05
  • Low Estimate 0.02
  • Prior Year 0.03
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.66 +11.79%
on 05/22/19
24.30 -4.98%
on 06/10/19
+0.17 (+0.74%)
since 05/14/19
3-Month
18.60 +24.14%
on 03/25/19
24.30 -4.98%
on 06/10/19
+3.32 (+16.79%)
since 03/14/19
52-Week
11.05 +108.96%
on 12/24/18
24.30 -4.98%
on 06/10/19
+9.98 (+76.13%)
since 06/14/18

Most Recent Stories

More News
Best Relative Performance in the Life Sciences Tools & Services Industry Detected in Shares of Illumina Inc (ILMN , NEO , TMO , PKI , BRKR )

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks...

ILMN : 344.00 (+0.80%)
TMO : 285.26 (-0.34%)
NEO : 23.09 (+0.35%)
Top 5 Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (PRAH , NSTG , NEO , ILMN , BRKR )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

NEO : 23.09 (+0.35%)
NSTG : 25.94 (+1.57%)
PRAH : 95.93 (-0.51%)
Relatively Good Performance Detected in Shares of Nanostring Techn in the Life Sciences Tools & Services Industry (NSTG , FLDM , NEO , BRKR , QGEN )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

NEO : 23.09 (+0.35%)
NSTG : 25.94 (+1.57%)
FLDM : 12.25 (+0.25%)
NeoGenomics To Present At 39th Annual William Blair Growth Stock Conference

FT. MYERS, FL / ACCESSWIRE / May 30, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that Doug VanOort, Chairman and Chief Executive...

NEO : 23.09 (+0.35%)
NeoGenomics To Attend The 16th Annual Craig-Hallum Institutional Investor Conference

FT. MYERS, FL / ACCESWIRE / May 23, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that Doug VanOort, Chief Executive Officer, Sharon...

NEO : 23.09 (+0.35%)
NeoGenomics Announces Proposed Public Offering of Common Stock

FT. MYERS, FL / ACCESSWIRE / May 20, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has commenced an underwritten public...

MS : 42.82 (-0.30%)
NEO : 23.09 (+0.35%)
Nanostring Techn has the Best Relative Performance in the Life Sciences Tools & Services Industry (NSTG , FLDM , NEO , A , TMO )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

NEO : 23.09 (+0.35%)
NSTG : 25.94 (+1.57%)
FLDM : 12.25 (+0.25%)
Nanostring Techn is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (NSTG , NEO , BRKR , QGEN , PACB )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

BRKR : 45.55 (-0.48%)
NEO : 23.09 (+0.35%)
NSTG : 25.94 (+1.57%)
Neogenomics Inc is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (NEO , PRAH , PKI , TMO , CRL )

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks...

NEO : 23.09 (+0.35%)
PRAH : 95.93 (-0.51%)
PKI : 92.94 (-0.18%)
Shares of Neogenomics Inc Rank the Highest in Terms of Relative Performance in the Life Sciences Tools & Services Industry (NEO , FLDM , WAT , BRKR , PKI )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

NEO : 23.09 (+0.35%)
WAT : 203.20 (-0.40%)
FLDM : 12.25 (+0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade NEO with:

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

2nd Resistance Point 23.80
1st Resistance Point 23.44
Last Price 23.09
1st Support Level 22.77
2nd Support Level 22.46

See More

52-Week High 24.30
Last Price 23.09
Fibonacci 61.8% 19.24
Fibonacci 50% 17.67
Fibonacci 38.2% 16.11
52-Week Low 11.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar